These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18628461)

  • 1. Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.
    Ulmer A; Beutel J; Süsskind D; Hilgers RD; Ziemssen F; Lüke M; Röcken M; Rohrbach M; Fierlbeck G; Bartz-Schmidt KU; Grisanti S
    Clin Cancer Res; 2008 Jul; 14(14):4469-74. PubMed ID: 18628461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
    Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S
    Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
    Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
    Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction.
    Tobal K; Sherman LS; Foss AJ; Lightman SL
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2622-5. PubMed ID: 8344785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ocular and metastatic uveal melanoma in an animal model.
    Blanco PL; Marshall JC; Antecka E; Callejo SA; Souza Filho JP; Saraiva V; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4376-82. PubMed ID: 16303923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of circulating melanoma cells in uveal melanoma patients by dual-marker immunoenrichment.
    Tura A; Lüke J; Merz H; Reinsberg M; Lüke M; Jager MJ; Grisanti S
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4395-404. PubMed ID: 24970258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients.
    Faye RS; Aamdal S; Høifødt HK; Jacobsen E; Holstad L; Skovlund E; Fodstad Ø
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4134-9. PubMed ID: 15217950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
    Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma inhibitory activity: a novel serum marker for uveal melanoma.
    Schaller UC; Bosserhoff AK; Neubauer AS; Buettner R; Kampik A; Mueller AJ
    Melanoma Res; 2002 Dec; 12(6):593-9. PubMed ID: 12459649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
    Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients.
    Eide N; Faye RS; Høifødt HK; Øvergaard R; Jebsen P; Kvalheim G; Fodstad Ø
    Acta Ophthalmol; 2009 Nov; 87(8):830-6. PubMed ID: 19055657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of monosomy-3 in immunomagnetically isolated circulating melanoma cells in uveal melanoma patients.
    Tura A; Merz H; Reinsberg M; Lüke M; Jager MJ; Grisanti S; Lüke J
    Pigment Cell Melanoma Res; 2016 Sep; 29(5):583-9. PubMed ID: 27390171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox.
    Eide N; Faye RS; Høifødt HK; Sandstad B; Qvale G; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
    Acta Ophthalmol; 2015 Feb; 93(1):59-66. PubMed ID: 25613126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells in uveal melanoma.
    Torres V; Triozzi P; Eng C; Tubbs R; Schoenfiled L; Crabb JW; Saunthararajah Y; Singh AD
    Future Oncol; 2011 Jan; 7(1):101-9. PubMed ID: 21174541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic nerve invasion of uveal melanoma: clinical characteristics and metastatic pattern.
    Lindegaard J; Isager P; Prause JU; Heegaard S
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3268-75. PubMed ID: 16877391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated tumour cells in bone marrow of patients with uveal melanoma.
    Eide N; Hoifødt HK; Nesland JM; Faye RS; Qvale GA; Faber RT; Jebsen P; Kvalheim G; Fodstad Ø
    Acta Ophthalmol; 2013 Jun; 91(4):343-8. PubMed ID: 22632270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study.
    Reiniger IW; Wolf A; Welge-Lüssen U; Mueller AJ; Kampik A; Schaller UC
    Am J Ophthalmol; 2007 Apr; 143(4):705-7. PubMed ID: 17386288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin and 'melanoma inhibitory activity': comparison of two serological tumor markers in metastatic uveal melanoma patients.
    Haritoglou I; Wolf A; Maier T; Haritoglou C; Hein R; Schaller UC
    Ophthalmologica; 2009; 223(4):239-43. PubMed ID: 19270465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.